2.8(top 6%)
Impact Factor
3.2(top 6%)
extended IF
47(top 9%)
H-Index
876
authors
1.1K
papers
13.2K
citations
2.5K
citing journals
12.8K
citing authors

Most Cited Articles of Expert Review of Hematology

TitleYearCitations
Mitochondria and Iron: current questions2017143
Relapse after allogeneic stem cell transplantation2010117
Allogeneic hematopoietic cell transplantation: the state of the art2010116
Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives2010109
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field2012108
Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders201099
Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders201398
Akt signaling in platelets and thrombosis201091
The bone marrow microenvironment and leukemia: biology and therapeutic targeting201187
Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health201184
Immunoglobulin light chain amyloidosis201483
Classification and therapeutic approaches in autoimmune hemolytic anemia: an update201183
Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis201381
Complications of thalassemia major and their treatment201181
D-dimer level in COVID-19 infection: a systematic review202078
Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up201175
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review201974
CXCL12 and CXCR4 in bone marrow physiology201074
Management of bone disease in multiple myeloma201473
Strategies to enhance umbilical cord blood stem cell engraftment in adult patients201072
JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms201065
Fondaparinux: does it cause HIT? Can it treat HIT?201065
Why factor XI deficiency is a clinical concern201665
Transfusion immunomodulation from a clinical perspective: an update201362
Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms201760